title: Does Pregabalin Still Have a Role in Treating Cancer-Induced Bone Pain?
authors.affiliation: Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Srinivas
authors.initials: S
authors.lastname: Raman
authors.affiliation: Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Carlo
authors.initials: C
authors.lastname: DeAngelis
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Eduardo
authors.initials: E
authors.lastname: Bruera
authors.affiliation: Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Ronald
authors.initials: R
authors.lastname: Chow
authors.affiliation: Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Breanne
authors.initials: B
authors.lastname: Lechner
authors.affiliation: Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Ontario, Canada edward.chow@sunnybrook.ca.
authors.forename: Edward
authors.initials: E
authors.lastname: Chow
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D059390:Breakthrough Pain / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications*; D010166:Palliative Care / Q000379:methods*; D000069583:Pregabalin / Q000627:therapeutic use*
chemical_list: D000700:Analgesics; D000069583:Pregabalin